G-CSF for Unexplained Recurrent Miscarriage During IVF
Part of Women’s health & pregnancy clinical trials.
This study tests whether G-CSF (a medicine that helps the immune system) given during IVF can reduce miscarriages in women who have had repeated pregnancy losses with no clear reason.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 44 years old.
- You have had at least 2 miscarriages with no known cause.
- You are having IVF and will test your embryos for normal chromosomes.
- Your body mass index (BMI) is between 19 and 35.
- You do not have any known chromosome problems, uterine issues, autoimmune disease, or blood clotting disorder.
- You have not used G-CSF before and are not allergic to it or E. coli proteins.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether immune system or microbiome changes in the uterus are linked to repeated IVF failure or recurrent miscarriage. The goal is to better understand why some women struggle to get pregnant or stay pregnant.
This trial tests whether a medicine called prednisolone can help prevent further miscarriages in people who have had recurrent miscarriages with no known cause. If you qualify, you would take prednisolone early in pregnancy and the study team would watch whether more losses occur.
This study looks for genetic clues in ongoing and past pregnancies to help explain why some people miscarry repeatedly. The results may help doctors better predict and prevent future pregnancy loss.
This trial tests whether a drug called thymosin-α1 can help women who have had two or more failed embryo transfers with genetically normal embryos. It aims to improve the chances of successful implantation.
This study looks at immune-related blood patterns and other measurements to better understand why some women have repeated pregnancy loss or repeated IVF implantation failure. If you qualify, your answers and test results may help researchers identify biomarkers that could guide future care.
This trial tests whether infusing a growth factor (G-CSF) into the uterus can help women with a thin uterine lining (≤7 mm) before embryo transfer. The goal is to improve pregnancy chances.
Hear when a new Recurrent Pregnancy Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.